Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome

Nature Genetics

Volumn 45, Issue 11, 2013, Pages 1284-1294

  Lessard, Christopher J ^a,b   Li, He ^a,b   Adrianto, Indra ^a   Ice, John A ^a   Rasmussen, Astrid ^a   Grundahl, Kiely M ^a   Kelly, Jennifer A ^a   Dozmorov, Mikhail G ^a   Miceli Richard, Corinne ^c   Bowman, Simon ^d   Lester, Sue ^e   Eriksson, Per ^f   Eloranta, Maija Leena ^g   Brun, Johan G ^h,i   Gøransson, Lasse G ^j   Harboe, Erna ^j   Guthridge, Joel M ^a   Kaufman, Kenneth M ^k,l   Kvarnström, Marika ^m   Jazebi, Helmi ^m,n   Graham, Deborah S Cunninghame ^o   Grandits, Martha E ^p   Nazmul Hossain, Abu N M ^q   Patel, Ketan ^r   Adler, Adam J ^a   Maier Moore, Jacen S ^a,b   Farris, A Darise ^a   Brennan, Michael T ^s   Lessard, James A ^t   Chodosh, James ^u   Gopalakrishnan, Rajaram ^r   Hefner, Kimberly S ^v   Houston, Glen D ^w   Huang, Andrew J W ^x   Hughes, Pamela J ^r   Lewis, David M ^w   Radfar, Lida ^w   Rohrer, Michael D ^r   Stone, Donald U ^b   Wren, Jonathan D ^a,b   Vyse, Timothy J ^o   Gaffney, Patrick M ^a   James, Judith A ^a,b   Omdal, Roald ^j   Wahren Herlenius, Marie ^m   Illei, Gabor G ^y   Witte, Torsten ^z   Jonsson, Roland ^h,i   Rischmueller, Maureen ^e,aa   Rönnblom, Lars ^g   Nordmark, Gunnel ^g   Ng, Wan Fai ^ab   Mariette, Xavier ^c   Anaya, Juan Manuel ^ac   Rhodus, Nelson L ^ad   Segal, Barbara M ^ae   Scofield, R Hal ^a,b,af   Montgomery, Courtney G ^a   Harley, John B ^k,l   Sivils, Kathy L ^a,b   more..

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^e QUEEN ELIZABETH HOSPITAL   (Australia)

^f LINKÖPING UNIVERSITY   (Sweden)

^g UPPSALA UNIVERSITY   (Sweden)

^h UNIVERSITY OF BERGEN   (Norway)

ⁱ HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^j STAVANGER UNIVERSITY HOSPITAL   (Norway)

^k CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^l VETERANS AFFAIRS MEDICAL CENTER   (United States)

^m KAROLINSKA INSTITUTE   (Sweden)

ⁿ ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^o KING'S COLLEGE LONDON   (United Kingdom)

^p St Paul MN ^*  (United States)

^q UNIVERSITY OF COLORADO   (United States)

^r UNIVERSITY OF MINNESOTA   (United States)

^s CAROLINAS MEDICAL CENTER   (United States)

^t Valley Bone and Joint Clinic   (United States)

^u HARVARD MEDICAL SCHOOL   (United States)

^v Hefner Eye Care and Optical Center   (United States)

^w UNIVERSITY OF OKLAHOMA   (United States)

^x WASHINGTON UNIVERSITY   (United States)

^y NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^z HANNOVER MEDICAL SCHOOL   (Germany)

^aa UNIVERSITY OF ADELAIDE   (Australia)

^ab NEWCASTLE UNIVERSITY   (United Kingdom)

^ac UNIVERSIDAD DEL ROSARIO   (Colombia)

^ad UNIVERSITY OF MINNESOTA   (United States)

^ae UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^af VETERANS AFFAIRS MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; CHEMOKINE RECEPTOR CXCR5; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 12P35; SECURIN; STAT4 PROTEIN;

ADAPTIVE IMMUNITY; ARTICLE; CASE CONTROL STUDY; CHROMATIN IMMUNOPRECIPITATION; CHROMOSOME 8; CONTROLLED STUDY; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HLA SYSTEM; HUMAN; INNATE IMMUNITY; INTRON; MAJOR CLINICAL STUDY; META ANALYSIS (TOPIC); PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SJOEGREN SYNDROME;

ADAPTIVE IMMUNITY; GENETIC ASSOCIATION STUDIES; GENETIC LOCI; GENETIC VARIATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNITY, INNATE; SJOGREN'S SYNDROME;

EID: 84887116043     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.2792     Document Type: Article

References (84)

1. Helmick, C.G. et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 58, 15-25 (2008
2. Pillemer, S.R. et al. Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesota. Mayo Clin. Proc. 76, 593-599 (2001
3. Plesivcnik Novljan, M. et al. Incidence of primary Sjögren's syndrome in Slovenia. Ann. Rheum. Dis. 63, 874-876 (2004
4. Jonsson, R. et al. The complexity of Sjögren's syndrome: Novel aspects on pathogenesis. Immunol. Lett. 141, 1-9 (2011
5. Vitali, C. et al. Classification criteria for Sjögren's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. 61, 554-558 (2002
6. Thanou-Stavraki, A. & James, J.A. Primary Sjögren's syndrome: Current and prospective therapies. Semin. Arthritis Rheum. 37, 273-292 (2008
7. Cobb, B.L., Lessard, C.J., Harley, J.B. & Moser, K.L. Genes and Sjögren's syndrome. Rheum. Dis. Clin. North Am. 34, 847-868 (2008
8. Hjelmervik, T.O., Petersen, K., Jonassen, I., Jonsson, R. & Bolstad, A.I. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects. Arthritis Rheum. 52, 1534-1544 (2005
9. Emamian, E.S. et al. Peripheral blood gene expression profiling in Sjögren's syndrome. Genes Immun. 10, 285-296 (2009
10. Ice, J.A. et al. Genetics of Sjögren's syndrome in the genome-wide association era. J. Autoimmun. 39, 57-63 (2012
11. Cruz-Tapias, P., Rojas-Villarraga, A., Maier-Moore, S. & Anaya, J.M. HLA and Sjögren's syndrome susceptibility. A meta-Analysis of worldwide studies. Autoimmun. Rev. 11, 281-287 (2012
12. Korman, B.D. et al. Variant form of STAT4 is associated with primary Sjögren's syndrome. Genes Immun. 9, 267-270 (2008
13. Miceli-Richard, C. et al. Association of an IRF5 gene functional polymorphism with Sjögren's syndrome. Arthritis Rheum. 56, 3989-3994 (2007
14. Nordmark, G. et al. Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjögren's syndrome. Genes Immun. 12, 100-109 (2011
15. Nordmark, G. et al. Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjögren's syndrome. Genes Immun. 10, 68-76 (2009
16. Kang, H.I. et al. Comparison of HLA class II genes in Caucasoid, Chinese, and Japanese patients with primary Sjögren's syndrome. J. Immunol. 150, 3615-3623 (1993
17. ENCODE Project Consortium. A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol. 9, e1001046 (2011
18. Rossin, E.J. et al. Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. PLoS Genet. 7, e1001273 (2011
19. Frisch, M., Klocke, B., Haltmeier, M. & Frech, K. LitInspector: Literature and signal transduction pathway mining in PubMed abstracts. Nucleic Acids Res. 37, W135-W140 (2009
20. Nekrep, N. et al. Mutation in a winged-helix DNA-binding motif causes atypical bare lymphocyte syndrome. Nat. Immunol. 3, 1075-1081 (2002
21. Meissner, T.B. et al. NLRC5 cooperates with the RFX transcription factor complex to induce MHC class I gene expression. J. Immunol. 188, 4951-4958 (2012
22. Loiseau, P. et al. HLA class I and class II are both associated with the genetic predisposition to primary Sjögren syndrome. Hum. Immunol. 62, 725-731 (2001
23. Raychaudhuri, S. et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat. Genet. 44, 291-296 (2012
24. Savitsky, D., Tamura, T., Yanai, H. & Taniguchi, T. Regulation of immunity and oncogenesis by the IRF transcription factor family. Cancer Immunol. Immunother. 59, 489-510 (2010
25. Takaoka, A. et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434, 243-249 (2005
26. Sigurdsson, S. et al. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am. J. Hum. Genet. 76, 528-537 (2005
27. Sigurdsson, S. et al. Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis. Arthritis Rheum. 56, 2202-2210 (2007
28. Stahl, E.A. et al. Genome-wide association study meta-Analysis identifies seven new rheumatoid arthritis risk loci. Nat. Genet. 42, 508-514 (2010
29. Dideberg, V. et al. An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases. Hum. Mol. Genet. 16, 3008-3016 (2007
30. Liu, X. et al. Genome-wide meta-Analyses identify three loci associated with primary biliary cirrhosis. Nat. Genet. 42, 658-660 (2010
31. Dieudé, P. et al. Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: A new perspective for pulmonary fibrosis. Arthritis Rheum. 60, 225-233 (2009
32. Radstake, T.R. et al. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat. Genet. 42, 426-429 (2010
33. Harley, J.B. et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat. Genet. 40, 204-210 (2008
34. Graham, R.R. et al. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc. Natl. Acad. Sci. USA 104, 6758-6763 (2007
35. Miceli-Richard, C. et al. The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjögren's syndrome. Arthritis Rheum. 60, 1991-1997 (2009
36. Sigurdsson, S. et al. Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus. Hum. Mol. Genet. 17, 872-881 (2008
37. Dawidowicz, K. et al. The interferon regulatory factor 5 gene confers susceptibility to rheumatoid arthritis and influences its erosive phenotype. Ann. Rheum. Dis. 70, 117-121 (2011
38. Kristjansdottir, G. et al. Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. J. Med. Genet. 45, 362-369 (2008
39. Kaplan, M.H. STAT4: A critical regulator of inflammation in vivo. Immunol. Res. 31, 231-242 (2005
40. Remmers, E.F. et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N. Engl. J. Med. 357, 977-986 (2007
41. Rueda, B. et al. The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype. Hum. Mol. Genet. 18, 2071-2077 (2009
42. Mells, G.F. et al. Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nat. Genet. 43, 329-332 (2011
43. Gestermann, N. et al. STAT4 is a confirmed genetic risk factor for Sjogren's syndrome and could be involved in type 1 interferon pathway signaling. Genes Immun. 11, 432-438 (2010
44. Watford, W.T. et al. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol. Rev. 202, 139-156 (2004
45. Xu, M. et al. Regulation of antitumor immune responses by the IL-12 family cytokines, IL-12, IL-23, and IL-27. Clin. Dev. Immunol. 2010, 832454 (2010
46. Hirschfield, G.M. et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N. Engl. J. Med. 360, 2544-2555 (2009
47. Hunt, K.A. et al. Newly identified genetic risk variants for celiac disease related to the immune response. Nat. Genet. 40, 395-402 (2008
48. Lessard, C.J. et al. Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. Am. J. Hum. Genet. 90, 648-660 (2012
49. Gottenberg, J.E. et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome. Proc. Natl. Acad. Sci. USA 103, 2770-2775 (2006
50. Pérez, P. et al. Gene expression and chromosomal location for susceptibility to Sjögren's syndrome. J. Autoimmun. 33, 99-108 (2009
51. Cornall, R.J. & Goodnow, C.C. B cell antigen receptor signalling in the balance of tolerance and immunity. Novartis Found. Symp. 215, 21-30 (1998
52. Nemazee, D. & Weigert, M. Revising B cell receptors. J. Exp. Med. 191, 1813-1817 (2000
53. Hom, G. et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N. Engl. J. Med. 358, 900-909 (2008
54. Simpfendorfer, K.R. et al. The autoimmunity-Associated BLK haplotype exhibits cis-regulatory effects on mRNA and protein expression that are prominently observed in B cells early in development. Hum. Mol. Genet. 21, 3918-3925 (2012
55. Sawcer, S. et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476, 214-219 (2011
56. Hansen, A., Lipsky, P.E. & Dorner, T. B cells in Sjögren's syndrome: Indications for disturbed selection and differentiation in ectopic lymphoid tissue. Arthritis Res. Ther. 9, 218 (2007
57. Ma, C.S. et al. Early commitment of naive human CD4+ T cells to the T follicular helper (TFH) cell lineage is induced by IL-12. Immunol. Cell Biol. 87, 590-600 (2009
58. Adrianto, I. et al. Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus. Nat. Genet. 43, 253-258 (2011
59. Uddin, M., Sturge, M., Rahman, P. & Woods, M.O. Autosome-wide copy number variation association analysis for rheumatoid arthritis using the WTCCC high-density SNP genotype data. J. Rheumatol. 38, 797-801 (2011
60. Allanore, Y. et al. Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis. PLoS Genet. 7, e1002091 (2011
61. Nair, R.P. et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways. Nat. Genet. 41, 199-204 (2009
62. Adrianto, I. et al. Two independent functional risk haplotypes in TNIP1 are associated with systemic lupus erythematosus. Arthritis Rheum. 64, 3695-3705 (2012
63. Gateva, V. et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat. Genet. 41, 1228-1233 (2009
64. Purcell, S. et al. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559-575 (2007
65. Cortes, A. & Brown, M.A. Promise and pitfalls of the Immunochip. Arthritis Res. Ther. 13, 101 (2011
66. Price, A.L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904-909 (2006
67. McKeigue, P.M., Carpenter, J.R., Parra, E.J. & Shriver, M.D. Estimation of admixture and detection of linkage in admixed populations by a Bayesian approach: Application to African-American populations. Ann. Hum. Genet. 64, 171-186 (2000
68. Halder, I., Shriver, M., Thomas, M., Fernandez, J.R. & Frudakis, T. A panel of ancestry informative markers for estimating individual biogeographical ancestry and admixture from four continents: Utility and applications. Hum. Mutat. 29, 648-658 (2008
69. Willer, C.J., Li, Y. & Abecasis, G.R. METAL: Fast and efficient meta-Analysis of genomewide association scans. Bioinformatics 26, 2190-2191 (2010
70. Cochran, W.G. The combination of estimates from different experiments. Biometrics 10, 101-129 (1954
71. Higgins, J.P., Thompson, S.G., Deeks, J.J. & Altman, D.G. Measuring inconsistency in meta-Analyses. Br. Med. J. 327, 557-560 (2003
72. Barrett, J.C., Fry, B., Maller, J. & Daly, M.J. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265 (2005
73. Pruim, R.J. et al. LocusZoom: Regional visualization of genome-wide association scan results. Bioinformatics 26, 2336-2337 (2010
74. Frazer, K.A. et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 449, 851-861 (2007
75. Howie, B.N., Donnelly, P. & Marchini, J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 5, e1000529 (2009
76. Via, M., Gignoux, C. & Burchard, E.G. The 1000 Genomes Project: New opportunities for research and social challenges. Genome Med. 2, 3 (2010
77. Zheng, X. et al. HIBAG-HLA genotype imputation with attribute bagging. Pharmacogenomics J. published online, doi:10.1038/tpj.2013.18 (28 May 2013
78. Barbosa-Morais, N.L. et al. A re-Annotation pipeline for Illumina BeadArrays: Improving the interpretation of gene expression data. Nucleic Acids Res. 38, e17 (2010
79. Irizarry, R.A. et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249-264 (2003
80. Johnson, W.E., Li, C. & Rabinovic, A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8, 118-127 (2007
81. Shabalin, A.A. Matrix eQTL: Ultra fast eQTL analysis via large matrix operations. Bioinformatics 28, 1353-1358 (2012
82. Dozmorov, M.G., Cara, L.R., Giles, C.B. & Wren, J.D. GenomeRunner: Automating genome exploration. Bioinformatics 28, 419-420 (2012
83. Fujita, P.A. et al. The UCSC Genome Browser database: Update 2011. Nucleic Acids Res. 39, D876-D882 (2011
84. Quinlan, A.R. & Hall, I.M. BEDTools: A flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841-842 (2010